Search research articles
Contact Us
Filters
Showing results (381-390 of 1,833) with videos related to
Page
of 184
Sort By:
Mabs
|
January 17, 2025
With great power, comes great responsibility: the importance of broadly measuring Fc-mediated effector function early in the antibody development process
Silvia Crescioli, Shashi Jatiani, Lenny Moise
Mabs
|
December 9, 2024
A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancer
Peter Jung, Stefan P Glaser, Jing Han, et al.
Mabs
|
December 5, 2023
Breaking barriers in antibody discovery: harnessing divergent species for accessing difficult and conserved drug targets
Soma S R Banik, Natasha Kushnir, Benjamin J Doranz, et al.
Mabs
|
March 27, 2024
In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies
Aimee E Mattei, Andres H Gutierrez, Soorya Seshadri, et al.
Mabs
|
March 26, 2024
RUBY® - a tetravalent (2+2) bispecific antibody format with excellent functionality and IgG-like stability, pharmacology and developability properties
Barnabas Nyesiga, Mattias Levin, Anna Säll, et al.
Mabs
|
September 17, 2024
Sequence-based engineering of pH-sensitive antibodies for tumor targeting or endosomal recycling applications
Wanlei Wei, Traian Sulea
Mabs
|
September 21, 2024
Discovery of potent allosteric antibodies inhibiting EGFR
Léxane Fournier, Lukas Pekar, Birgitta Leuthner, et al.
Mabs
|
September 22, 2024
Systematic analysis of Fc mutations designed to enhance binding to Fc-gamma receptors
Geoff Hale, Alastair Douglas Davy, Ian Wilkinson
Mabs
|
March 6, 2024
Exploring molecular determinants and pharmacokinetic properties of IgG1-scFv bispecific antibodies
Kristina M J Aertker, Minu Ravindra Pilvankar, Tobias M Prass, et al.
Mabs
|
March 6, 2024
A novel conditional active biologic anti-EpCAM x anti-CD3 bispecific antibody with synergistic tumor selectivity for cancer immunotherapy
Gerhard Frey, Ana Paula G Cugnetti, Haizhen Liu, et al.
Page
of 184
Search research articles
Search
Showing results (381-390 of 1,833) with videos related to
Sort By:
Page
of 184
Mabs
|
January 17, 2025
With great power, comes great responsibility: the importance of broadly measuring Fc-mediated effector function early in the antibody development process
Silvia Crescioli, Shashi Jatiani, Lenny Moise
Mabs
|
December 9, 2024
A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancer
Peter Jung, Stefan P Glaser, Jing Han, et al.
Mabs
|
December 5, 2023
Breaking barriers in antibody discovery: harnessing divergent species for accessing difficult and conserved drug targets
Soma S R Banik, Natasha Kushnir, Benjamin J Doranz, et al.
Mabs
|
March 27, 2024
In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies
Aimee E Mattei, Andres H Gutierrez, Soorya Seshadri, et al.
Mabs
|
March 26, 2024
RUBY® - a tetravalent (2+2) bispecific antibody format with excellent functionality and IgG-like stability, pharmacology and developability properties
Barnabas Nyesiga, Mattias Levin, Anna Säll, et al.
Mabs
|
September 17, 2024
Sequence-based engineering of pH-sensitive antibodies for tumor targeting or endosomal recycling applications
Wanlei Wei, Traian Sulea
Mabs
|
September 21, 2024
Discovery of potent allosteric antibodies inhibiting EGFR
Léxane Fournier, Lukas Pekar, Birgitta Leuthner, et al.
Mabs
|
September 22, 2024
Systematic analysis of Fc mutations designed to enhance binding to Fc-gamma receptors
Geoff Hale, Alastair Douglas Davy, Ian Wilkinson
Mabs
|
March 6, 2024
Exploring molecular determinants and pharmacokinetic properties of IgG1-scFv bispecific antibodies
Kristina M J Aertker, Minu Ravindra Pilvankar, Tobias M Prass, et al.
Mabs
|
March 6, 2024
A novel conditional active biologic anti-EpCAM x anti-CD3 bispecific antibody with synergistic tumor selectivity for cancer immunotherapy
Gerhard Frey, Ana Paula G Cugnetti, Haizhen Liu, et al.
Page
of 184